A phase II study of oral MKC-1 for metastatic breast cancer (MBC)

Autor:	M. A. Taylor, L. Laufman, J. Arnott, Kathy D. Miller, Bryan P. Schneider, Alison L. Hannah, M. Karwal, C. Sidor, L. Sylvester
Rok vydání:	2008
Předmět:	Cancer Research business.industry Phases of clinical research Tumor cells Pharmacology Cell cycle medicine.disease Metastatic breast cancer In vitro Breast cancer Oncology In vivo Cancer research Medicine business
Zdroj:	Journal of Clinical Oncology. 26:1046-1046
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2008.26.15_suppl.1046
Popis:	1046 Background: MKC-1 is a novel oral cell cycle inhibitor with in vitro and in vivo activity against many tumor cell lines, including breast cancer. Proteins identified as binding targets of MKC-...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::136e97284653d7f8f5162a322afb45bc https://doi.org/10.1200/jco.2008.26.15_suppl.1046 Zobrazit plný text záznamu